Guardian Pharmacy Services, Inc. (NYSE:GRDN) Receives $32.00 Consensus Price Target from Analysts

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) have been given an average rating of “Moderate Buy” by the five brokerages that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $32.00.

A number of brokerages have recently issued reports on GRDN. Truist Financial upped their target price on shares of Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a research report on Friday, November 14th. Wall Street Zen raised Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a report on Monday, November 17th. Stephens increased their price objective on Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an “overweight” rating in a research report on Wednesday, January 14th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research report on Monday, December 29th.

Guardian Pharmacy Services Price Performance

Shares of GRDN opened at $33.47 on Friday. The business’s 50 day simple moving average is $30.83 and its 200-day simple moving average is $27.97. The company has a market capitalization of $2.12 billion, a P/E ratio of 53.13 and a beta of 0.96. Guardian Pharmacy Services has a one year low of $17.78 and a one year high of $37.43.

Institutional Investors Weigh In On Guardian Pharmacy Services

Several institutional investors have recently modified their holdings of GRDN. State of Alaska Department of Revenue acquired a new position in Guardian Pharmacy Services in the third quarter valued at approximately $30,000. Parkside Financial Bank & Trust bought a new stake in shares of Guardian Pharmacy Services during the 2nd quarter valued at $41,000. Ameritas Investment Partners Inc. boosted its position in shares of Guardian Pharmacy Services by 26.5% in the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after purchasing an additional 345 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Guardian Pharmacy Services during the second quarter worth $43,000. Finally, Police & Firemen s Retirement System of New Jersey increased its holdings in Guardian Pharmacy Services by 76.8% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock valued at $52,000 after purchasing an additional 1,062 shares during the last quarter.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.